AU1843595A - Methods for stimulating erythropoiesis using thrombopoietin - Google Patents
Methods for stimulating erythropoiesis using thrombopoietinInfo
- Publication number
- AU1843595A AU1843595A AU18435/95A AU1843595A AU1843595A AU 1843595 A AU1843595 A AU 1843595A AU 18435/95 A AU18435/95 A AU 18435/95A AU 1843595 A AU1843595 A AU 1843595A AU 1843595 A AU1843595 A AU 1843595A
- Authority
- AU
- Australia
- Prior art keywords
- sequence
- residue
- seq
- amino acid
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/196—Thrombopoietin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0642—Granulocytes, e.g. basopils, eosinophils, neutrophils, mast cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/145—Thrombopoietin [TPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU33975/99A AU725159B2 (en) | 1994-02-14 | 1999-06-10 | Methods for stimulating erythropoiesis using thrombopoietin |
Applications Claiming Priority (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19602594A | 1994-02-14 | 1994-02-14 | |
US196025 | 1994-02-14 | ||
US20319794A | 1994-02-25 | 1994-02-25 | |
US203197 | 1994-02-25 | ||
US21520394A | 1994-03-21 | 1994-03-21 | |
US215203 | 1994-03-21 | ||
US25249194A | 1994-06-01 | 1994-06-01 | |
US252491 | 1994-06-01 | ||
US28841794A | 1994-08-09 | 1994-08-09 | |
US288417 | 1994-08-09 | ||
US33556694A | 1994-11-07 | 1994-11-07 | |
US335566 | 1994-11-07 | ||
US34774894A | 1994-12-01 | 1994-12-01 | |
US347748 | 1994-12-01 | ||
PCT/US1995/001829 WO1995021626A1 (fr) | 1994-02-14 | 1995-02-09 | Procede de stimulation de l'erythropoiese a l'aide de proteines hematopoietiques |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU33975/99A Division AU725159B2 (en) | 1994-02-14 | 1999-06-10 | Methods for stimulating erythropoiesis using thrombopoietin |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1843595A true AU1843595A (en) | 1995-08-29 |
Family
ID=27569260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU18435/95A Abandoned AU1843595A (en) | 1994-02-14 | 1995-02-09 | Methods for stimulating erythropoiesis using thrombopoietin |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0723456A1 (fr) |
AU (1) | AU1843595A (fr) |
CA (1) | CA2169173C (fr) |
FI (1) | FI960930A (fr) |
NZ (1) | NZ281482A (fr) |
WO (1) | WO1995021626A1 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5733761A (en) | 1991-11-05 | 1998-03-31 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
US6270989B1 (en) * | 1991-11-05 | 2001-08-07 | Transkaryotic Therapies, Inc. | Protein production and delivery |
US6316254B1 (en) * | 1994-02-14 | 2001-11-13 | University Of Washington | Methods for stimulating erythropoiesis using hematopoietic proteins |
WO1995026746A1 (fr) * | 1994-03-31 | 1995-10-12 | Amgen Inc. | Compositions et methodes de stimulation de la croissance et de la differentiation des megacaryocytes |
US5795569A (en) * | 1994-03-31 | 1998-08-18 | Amgen Inc. | Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation |
TW434021B (en) * | 1995-03-15 | 2001-05-16 | Kirin Brewery | Methods for preventing adsorption of thrombopoietin (TPO), and stable TPO-containing compositions |
TW434020B (en) * | 1995-03-15 | 2001-05-16 | Kirin Brewery | Methods for preventing adsorption of thrombopoietin (TPO), and stable top-containing compositions |
US6251864B1 (en) | 1995-06-07 | 2001-06-26 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
EP1961760A3 (fr) | 1995-06-07 | 2008-09-03 | Glaxo Group Limited | Peptides et composés se liant à un récepteur de la thrombopoïétine |
US5869451A (en) * | 1995-06-07 | 1999-02-09 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
TW497972B (en) * | 1995-06-08 | 2002-08-11 | Kirin Brewery | Stable thrombopoietin (TPO)-containing lyophilized compositions |
US6060052A (en) * | 1995-10-30 | 2000-05-09 | Systemix, Inc. | Methods for use of Mpl ligands with primitive human hematopoietic stem cells |
US7091311B2 (en) | 1996-06-07 | 2006-08-15 | Smithkline Beecham Corporation | Peptides and compounds that bind to a receptor |
WO2002015926A1 (fr) * | 2000-08-24 | 2002-02-28 | Kirin Beer Kabushiki Kaisha | Compositions medicinales contenant des ligands c-mpl, destinees a l'augmentation des plaquettes et des erythrocytes |
DK1542714T3 (da) | 2002-09-18 | 2014-05-26 | Janssen Pharmaceuticals Inc | Fremgangsmåder til forøgelse af produktion af blodplader og hæmatopoietiske stamceller |
CN102241742B (zh) | 2003-08-28 | 2014-04-02 | 奥索-麦克尼尔药品公司 | 结合血小板生成素受体的肽和化合物 |
US7723295B2 (en) | 2003-08-28 | 2010-05-25 | Ortho-Mcneil Pharmaceutical, Inc. | Peptides and compounds that bind to a receptor |
US7615533B2 (en) | 2004-08-16 | 2009-11-10 | Janssen Pharmaceutica N.V. | TPO peptide compounds for treatment of anemia |
US7879318B2 (en) * | 2006-01-23 | 2011-02-01 | Mcw Research Foundation, Inc. | Method of reducing the effects of ischemia by administration of a thrombopoietin receptor ligand |
ES2516649T3 (es) * | 2006-02-14 | 2014-10-31 | Janssen Pharmaceutica Nv | Uso de compuestos péptidos de TPO y composiciones farmacéuticas en el tratamiento de la anemia |
-
1995
- 1995-02-09 CA CA002169173A patent/CA2169173C/fr not_active Expired - Fee Related
- 1995-02-09 WO PCT/US1995/001829 patent/WO1995021626A1/fr not_active Application Discontinuation
- 1995-02-09 AU AU18435/95A patent/AU1843595A/en not_active Abandoned
- 1995-02-09 NZ NZ281482A patent/NZ281482A/xx unknown
- 1995-02-09 EP EP95910252A patent/EP0723456A1/fr not_active Withdrawn
-
1996
- 1996-02-28 FI FI960930A patent/FI960930A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
WO1995021626A1 (fr) | 1995-08-17 |
EP0723456A1 (fr) | 1996-07-31 |
CA2169173A1 (fr) | 1995-08-17 |
FI960930A0 (fi) | 1996-02-28 |
NZ281482A (en) | 2000-09-29 |
CA2169173C (fr) | 2002-10-15 |
FI960930A (fi) | 1996-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5989537A (en) | Methods for stimulating granulocyte/macrophage lineage using thrombopoietin | |
AU1843595A (en) | Methods for stimulating erythropoiesis using thrombopoietin | |
Hirayama et al. | The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors | |
Carver-Moore et al. | Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice | |
Borge et al. | Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro | |
AU689373B2 (en) | Method for secreting thrombopoietin polypeptides | |
EP0892849B1 (fr) | Procedes d'utilisation du gene obese et de son produit genique afin de stimuler le developpement des cellules hematopo etiques | |
Tong et al. | In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells | |
US6316254B1 (en) | Methods for stimulating erythropoiesis using hematopoietic proteins | |
AU693032B2 (en) | Methods for increasing hematopoietic cells | |
EP0639979B1 (fr) | LIGAND POUR LE RECEPTEUR DE c-$i(KIT) ET PROCEDES D'UTILISATION | |
US6099830A (en) | Methods for stimulating erythropoiesis using hematopoietic proteins | |
WO1996017062A1 (fr) | Thrombopoietine de faible poids moleculaire | |
EP0804480A1 (fr) | Thrombopoietine purifiee et son procede d'obtention | |
CA2433933A1 (fr) | Utilisation de lp82 pour traiter les troubles hematopoietiques | |
AU725159B2 (en) | Methods for stimulating erythropoiesis using thrombopoietin | |
AU723793B2 (en) | Hematopoietic protein and materials and methods for making it | |
MXPA97009244A (en) | Methods to increase hematopoyeti cells | |
Tong et al. | In vivo administration of recombinant methionyl human stem cell | |
AU5966796A (en) | Therapy using lymphotoxin and thrombopoietin |